CLIA: 39D2085645
New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval.
Lung Cancer
Commentary on: Does screening for disease save lives in asymptomatic adults? Systematic review of 5 meta-analyses and randomized trials
By Drs. Squib and Ioannidis
Proteomic Analysis of Human Saliva From Lung Cancer Patients Using Two-Dimensional Difference Gel Electrophoresis and Mass Spectrometry
By Hua Xiao, Lei Zhang, Hui Zhou, Jay M. Lee, Edward B. Garon, and David T. Wong
Development of Transcriptomic Biomarker Signature in Human Saliva to Detect Lung Cancer
By Lei Zhang, Hua Xiao, Hui Zhou, Silverio Santiago, Jay M. Lee, Edward B. Garon, Jieping Yang, Ole Brinkmann, Xinmin Yan, David Akin, David Chia, David Elashoff, No-Hee Park, David T. W. Wong